| Horus Pharma Suisse SA - Latazed 50 ug/ml, collyre en solution |
| 69656 | | 01 | | Latazed 50 ug/ml | | collyre en solution | | S01EE01 | | Latanoprost | | 31.03.2025 | | |
|
| Composition |
| latanoprostum 0.05 mg, macrogolglyceroli hydroxystearas 25 mg, natrii chloridum, dinatrii edetas, natrii dihydrogenophosphas dihydricus et dinatrii phosphas corresp. phosphas 6.35 mg, acidum hydrochloridum aut natrii hydroxidum ad pH, aqua ad iniectabile, ad solutionem pro 1 ml. |
| Packungsbestandteile |
| | | | | | | Active Agent | Dose |
|---|
| Latanoprost | 0.05 mg/ml |
| | | | Inactive agents | Dose |
|---|
| | | | | | | Disodium Phosphate | | | | 25 mg/ml | | Sodium Chloride | | | Sodium Dihydrogenophosphate Dihydrate | |
|
|
|
